GGTLC1

Across TCGA pan-cancer cohorts, GGTLC1 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated GGTLC1 data layer compared with 20 for mass-spec protein.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher GGTLC1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated GGTLC1 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

OV, LIHC, and UCEC are the cancer types where GGTLC1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Median	II,III,IV	0.323	0.843	.001	18	view →
LIHC	OS	Median	All	0.260	0.707	.020	9	view →
UCEC	DFS	Median	All	1.000	0.635	.034	4	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

GGTLC1–OV (OS)

Open the OV breakdown →